KR101713581B1 - Ｈｉｇ２ 및 ｕｒｌｃ１０ 에피토프 펩티드 및 이를 포함하는 백신 - Google Patents

Ｈｉｇ２ 및 ｕｒｌｃ１０ 에피토프 펩티드 및 이를 포함하는 백신 Download PDF

Info

Publication number
KR101713581B1
KR101713581B1 KR1020117005809A KR20117005809A KR101713581B1 KR 101713581 B1 KR101713581 B1 KR 101713581B1 KR 1020117005809 A KR1020117005809 A KR 1020117005809A KR 20117005809 A KR20117005809 A KR 20117005809A KR 101713581 B1 KR101713581 B1 KR 101713581B1
Authority
KR
South Korea
Prior art keywords
hla
peptide
cancer
antigen
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020117005809A
Other languages
English (en)
Korean (ko)
Other versions
KR20110045052A (ko
Inventor
타쿠야 츠노다
류지 오사와
사치코 요시무라
Original Assignee
온코세라피 사이언스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코세라피 사이언스 가부시키가이샤 filed Critical 온코세라피 사이언스 가부시키가이샤
Publication of KR20110045052A publication Critical patent/KR20110045052A/ko
Application granted granted Critical
Publication of KR101713581B1 publication Critical patent/KR101713581B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020117005809A 2008-08-19 2009-08-14 Ｈｉｇ２ 및 ｕｒｌｃ１０ 에피토프 펩티드 및 이를 포함하는 백신 Active KR101713581B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19
US61/089,972 2008-08-19
PCT/JP2009/003897 WO2010021112A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Publications (2)

Publication Number Publication Date
KR20110045052A KR20110045052A (ko) 2011-05-03
KR101713581B1 true KR101713581B1 (ko) 2017-03-08

Family

ID=41707003

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117005809A Active KR101713581B1 (ko) 2008-08-19 2009-08-14 Ｈｉｇ２ 및 ｕｒｌｃ１０ 에피토프 펩티드 및 이를 포함하는 백신

Country Status (16)

Country Link
US (1) US9119800B2 (https=)
EP (1) EP2328600B9 (https=)
JP (1) JP5633025B2 (https=)
KR (1) KR101713581B1 (https=)
CN (2) CN102186491B (https=)
AU (1) AU2009283763B2 (https=)
BR (1) BRPI0917391A2 (https=)
CA (1) CA2734467C (https=)
DK (1) DK2328600T3 (https=)
ES (1) ES2566011T3 (https=)
IL (1) IL211117A (https=)
MX (2) MX337756B (https=)
RU (1) RU2529373C2 (https=)
SG (2) SG193806A1 (https=)
TW (2) TWI580431B (https=)
WO (1) WO2010021112A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
SMT201800444T1 (it) * 2010-11-17 2018-09-13 Aduro Biotech Inc Metodi e composizioni per indurre una risposta immunitaria contro egfrviii
WO2014010232A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Ly6k epitope peptides for th1 cells and vaccines containing the same
SG11201700838VA (en) 2014-08-04 2017-03-30 Oncotherapy Science Inc Urlc10-derived peptide and vaccine containing same
AU2016306408B2 (en) 2015-08-10 2021-02-11 Toray Industries, Inc. Immune inducer
CA2994929A1 (en) 2015-08-12 2017-02-16 Oncotherapy Science, Inc. Depdc1-derived peptide and vaccine containing same
JP7538601B2 (ja) 2017-04-26 2024-08-22 ユーリカ セラピューティックス， インコーポレイテッド キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用
BR112019027133B8 (pt) 2017-06-20 2022-08-09 Inst Curie Uso de uma célula imune modificada deficiente para suv39h1
CN115300609A (zh) * 2021-05-08 2022-11-08 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用
CN120842356A (zh) * 2025-07-25 2025-10-28 广西医科大学附属肿瘤医院 Ly6k抗原表位肽、组合物及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011044A1 (fr) 1999-08-05 2001-02-15 Kyogo Itoh Antigene de tumeur
WO2005019475A2 (en) 2003-08-20 2005-03-03 Oncotherapy Science, Inc. Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
WO2006090810A2 (en) * 2005-02-25 2006-08-31 Oncotherapy Science, Inc. Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
WO2007029778A1 (ja) 2005-09-07 2007-03-15 Nec Corporation Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
WO2001023426A2 (en) 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
EP1474528A4 (en) 2000-10-13 2006-06-14 Protein Design Labs Inc METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF EXAMINING PROSTATE CANCER MODULATORS
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2570392A1 (en) 2004-06-21 2005-12-29 Green Peptide Co., Ltd. Peptide vaccine for cancer therapy
CN101175862A (zh) 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
CA2599875A1 (en) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
WO2007013575A2 (en) 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
JP4840858B2 (ja) 2006-03-16 2011-12-21 学校法人慶應義塾 癌ワクチン
AU2007259667B2 (en) * 2006-06-16 2012-06-14 Oncotherapy Science, Inc. SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
WO2009016691A1 (en) 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011044A1 (fr) 1999-08-05 2001-02-15 Kyogo Itoh Antigene de tumeur
WO2005019475A2 (en) 2003-08-20 2005-03-03 Oncotherapy Science, Inc. Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
WO2006090810A2 (en) * 2005-02-25 2006-08-31 Oncotherapy Science, Inc. Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
WO2007029778A1 (ja) 2005-09-07 2007-03-15 Nec Corporation Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター

Also Published As

Publication number Publication date
RU2529373C2 (ru) 2014-09-27
AU2009283763A1 (en) 2010-02-25
JP5633025B2 (ja) 2014-12-03
HK1157204A1 (zh) 2012-06-29
CA2734467A1 (en) 2010-02-25
CA2734467C (en) 2017-10-03
MX337756B (es) 2016-03-17
JP2012500184A (ja) 2012-01-05
IL211117A0 (en) 2011-04-28
AU2009283763A2 (en) 2011-07-07
CN104958753B (zh) 2018-09-25
EP2328600A4 (en) 2013-03-06
SG10201610206VA (en) 2017-01-27
US20110243973A1 (en) 2011-10-06
MX355054B (es) 2018-04-03
EP2328600B9 (en) 2016-07-13
BRPI0917391A2 (pt) 2015-12-01
CN102186491B (zh) 2015-06-10
US9119800B2 (en) 2015-09-01
TWI580431B (zh) 2017-05-01
TW201019952A (en) 2010-06-01
IL211117A (en) 2017-03-30
DK2328600T3 (en) 2016-03-29
KR20110045052A (ko) 2011-05-03
WO2010021112A1 (en) 2010-02-25
EP2328600A1 (en) 2011-06-08
MX2011001883A (es) 2011-03-29
TWI543767B (zh) 2016-08-01
CN104958753A (zh) 2015-10-07
SG193806A1 (en) 2013-10-30
ES2566011T3 (es) 2016-04-08
EP2328600B1 (en) 2016-01-27
CN102186491A (zh) 2011-09-14
RU2011110376A (ru) 2012-09-27
TW201500055A (zh) 2015-01-01
AU2009283763B2 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
KR101713581B1 (ko) Ｈｉｇ２ 및 ｕｒｌｃ１０ 에피토프 펩티드 및 이를 포함하는 백신
KR101705011B1 (ko) Ｃｄｃａ１ 에피토프 펩티드 및 이를 포함하는 백신
US20110280898A1 (en) Inhbb epitope peptides and vaccines containing the same
EP2508601B1 (en) Tem8 peptides and vaccines comprising the same
KR101705514B1 (ko) Ｍｅｌｋ 에피토프 펩티드 및 이를 포함하는 백신
KR20110036903A (ko) Ｉｑｇａｐ３ 에피토프 펩티드 및 이를 포함하는 백신
US20110189213A1 (en) Mybl2 epitope peptides and vaccines containing the same
KR101705102B1 (ko) Ｗｄｒｐｕｈ 에피토프 펩티드 및 이를 포함하는 백신
HK1157204B (en) Hig2 and urlc10 epitope peptide and vaccines containing the same
HK1155757A (en) Cdca1 epitope peptides and vaccines containing the same
HK1155757B (en) Cdca1 epitope peptides and vaccines containing the same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110311

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140812

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160217

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160823

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20161226

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20170302

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20170303

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20200221

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20200221

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20210219

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20210219

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20220218

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20220218

Start annual number: 6

End annual number: 6